US Patent Issued to Exopharma on March 31 for "Mesenchymal stem cell-derived extracellular vesicles and uses thereof for treating and diagnosing fibrotic diseases" (Florida, New York Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,589,117, issued on March 31, was assigned to Exopharma Inc (Miami).

"Mesenchymal stem cell-derived extracellular vesicles and uses thereof for treating and diagnosing fibrotic diseases" was invented by Marilyn Glassberg Csete (Miami), Sharon Elliot (Miami) and Robin Smith (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "The described invention provides compositions and methods for treating a fibrotic condition in a subject. The methods include administering a therapeutic amount of a pharmaceutical composition comprising synthetic extracellular vesicles (EVs) and a pharmaceutically acceptable carrier."

The patent was filed on July 18, 2022, und...